Diffusion weighted MRI in chronic viral hepatitis: correlation between ADC values and histopathological scores
- PMID: 23666523
- PMCID: PMC3675251
- DOI: 10.1007/s13244-013-0252-x
Diffusion weighted MRI in chronic viral hepatitis: correlation between ADC values and histopathological scores
Abstract
Objective: To investigate the utility of apparent diffusion coefficient (ADC) measurement in the diagnosis of chronic viral hepatitis (CVH) and correlation between ADC values and histopathologic severity of CVH.
Materials and methods: The ADC values of liver parenchyma on diffusion-weighted magnetic resonance imaging (DWMRI) were measured in 50 patients with a history of CVH and 51 healthy subjects at b 100, b 600 and b 1,000 gradients. Comparison between mean ADC values of the CVH and control groups and correlation results between ADC values and necroinflammation and fibrosis scores in CVH were obtained.
Results: Mean ADC values of CVH patients were significantly lower than mean ADC values of the control group at b 100 and b 600 gradients (P < 0.05). There was no significant difference between the CVH and control groups at the b 1,000 gradient (P > 0.05). No significant correlation was found between ADC values and histopathologic scores of CVH (P > 0.05).
Conclusion: ADC values obtained at the b 100 and b 600 gradients can be used to distinguish between the liver parenchyma of CVH and healthy subjects. ADC measurement was not found to be useful for estimation of the degree of necroinflammation and fibrosis in CVH.
Teaching points: • In chronic viral hepatitis apparent coefficient values are decreased in the liver • There is no correlation between ADC values and histopathologic severity of CVH • DW images obtained at low b values have more ability to demonstrate an ADC decrease in viral hepatitis.
Figures
Similar articles
-
Assessment of Liver Fibrosis with Diffusion-Weighted Magnetic Resonance Imaging Using Different b-values in Chronic Viral Hepatitis.Med Princ Pract. 2015;24(6):522-6. doi: 10.1159/000434682. Epub 2015 Jul 16. Med Princ Pract. 2015. PMID: 26183515 Free PMC article.
-
Utility of diffusion-weighted MRI for assessing liver fibrosis in patients with chronic active hepatitis.Diagn Interv Radiol. 2010 Sep;16(3):204-8. doi: 10.4261/1305-3825.DIR.2810-09.1. Epub 2010 Jul 25. Diagn Interv Radiol. 2010. PMID: 20658448
-
Evaluation of the mean and entropy of apparent diffusion coefficient values in chronic hepatitis C: correlation with pathologic fibrosis stage and inflammatory activity grade.Radiology. 2011 Mar;258(3):739-48. doi: 10.1148/radiol.10100853. Epub 2011 Jan 19. Radiology. 2011. PMID: 21248235
-
Apparent diffusion coefficient measurement of the parotid gland parenchyma.Quant Imaging Med Surg. 2021 Aug;11(8):3812-3829. doi: 10.21037/qims-20-1178. Quant Imaging Med Surg. 2021. PMID: 34341752 Free PMC article. Review.
-
Magnetic resonance diffusion-weighted imaging: extraneurological applications.Radiol Med. 2006 Apr;111(3):392-419. doi: 10.1007/s11547-006-0037-0. Epub 2006 Apr 11. Radiol Med. 2006. PMID: 16683086 Review. English, Italian.
Cited by
-
Noninvasive Biomarkers of Liver Fibrosis: Clinical Applications and Future Directions.Curr Pathobiol Rep. 2014 Dec 1;2(4):245-256. doi: 10.1007/s40139-014-0061-z. Curr Pathobiol Rep. 2014. PMID: 25396099 Free PMC article.
-
Quantitative magnetic resonance imaging for chronic liver disease.Br J Radiol. 2021 May 1;94(1121):20201377. doi: 10.1259/bjr.20201377. Epub 2021 Feb 26. Br J Radiol. 2021. PMID: 33635729 Free PMC article. Review.
-
The impact of the mesorectal apparent diffusion coefficient value on surgical difficulty in laparoscopic anterior resection for rectal cancer.Surg Today. 2019 Mar;49(3):239-244. doi: 10.1007/s00595-018-1727-7. Epub 2018 Oct 19. Surg Today. 2019. PMID: 30341539
-
PET/DW-MRI for evaluating treatment in chronic hepatitis C patients.Am J Nucl Med Mol Imaging. 2019 Feb 15;9(1):84-92. eCollection 2019. Am J Nucl Med Mol Imaging. 2019. PMID: 30911438 Free PMC article.
-
Magnetic Resonance imaging analysis of liver fibrosis and inflammation: overwhelming gray zones restrict clinical use.Abdom Radiol (NY). 2020 Nov;45(11):3557-3568. doi: 10.1007/s00261-020-02713-1. Epub 2020 Aug 28. Abdom Radiol (NY). 2020. PMID: 32857259 Review.
References
-
- Lawrence SP. Advances in the treatment of hepatitis C. Adv Intern Med. 2000;45:65–105. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources